Ultimovacs

Developer of next-generation cell therapies for solid tumors

placeOslo, Oslo, Norway calendar_todayFounded 2011 groups25 employees language ultimovacs.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon